VIKING GLOBAL INVESTORS LP 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:01 pm Unchanged | 2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS | VIKING GLOBAL INVESTORS LP | 328,962 8.000% | 0 (Unchanged) | Filing |
| 2021-05-17 1:25 pm Purchase | 2021-05-07 | 13G | Talaris Therapeutics, Inc. TALS | VIKING GLOBAL INVESTORS LP | 328,962 8.200% | 328,962 (New Position) | Filing |